A detailed history of Mutual Of America Capital Management LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Mutual Of America Capital Management LLC holds 67,187 shares of ARWR stock, worth $1.45 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
67,187
Previous 71,111 5.52%
Holding current value
$1.45 Million
Previous $1.85 Million 29.65%
% of portfolio
0.01%
Previous 0.02%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$19.36 - $29.54 $75,968 - $115,914
-3,924 Reduced 5.52%
67,187 $1.3 Million
Q2 2024

Aug 09, 2024

SELL
$21.87 - $28.24 $59,377 - $76,671
-2,715 Reduced 3.68%
71,111 $1.85 Million
Q1 2024

May 02, 2024

BUY
$27.21 - $39.48 $206,714 - $299,929
7,597 Added 11.47%
73,826 $2.11 Million
Q4 2023

Jan 26, 2024

SELL
$21.2 - $31.03 $994,343 - $1.46 Million
-46,903 Reduced 41.46%
66,229 $2.03 Million
Q3 2023

Nov 09, 2023

SELL
$26.2 - $36.08 $289,326 - $398,431
-11,043 Reduced 8.89%
113,132 $3.04 Million
Q2 2023

Aug 11, 2023

SELL
$25.16 - $41.38 $314,550 - $517,332
-12,502 Reduced 9.15%
124,175 $4.43 Million
Q1 2023

May 04, 2023

SELL
$23.68 - $38.51 $50,367 - $81,910
-2,127 Reduced 1.53%
136,677 $3.47 Million
Q4 2022

Feb 10, 2023

BUY
$28.0 - $40.56 $73,052 - $105,821
2,609 Added 1.92%
138,804 $5.63 Million
Q3 2022

Nov 08, 2022

BUY
$29.63 - $48.31 $58,963 - $96,136
1,990 Added 1.48%
136,195 $4.5 Million
Q2 2022

Aug 10, 2022

SELL
$27.79 - $50.61 $225,738 - $411,105
-8,123 Reduced 5.71%
134,205 $4.73 Million
Q1 2022

May 02, 2022

BUY
$39.62 - $69.97 $36,648 - $64,722
925 Added 0.65%
142,328 $6.55 Million
Q4 2021

Feb 03, 2022

BUY
$58.09 - $82.51 $51,293 - $72,856
883 Added 0.63%
141,403 $9.38 Million
Q3 2021

Nov 10, 2021

BUY
$58.38 - $84.96 $64,860 - $94,390
1,111 Added 0.8%
140,520 $8.77 Million
Q2 2021

Aug 06, 2021

SELL
$62.15 - $90.32 $1.82 Million - $2.64 Million
-29,231 Reduced 17.33%
139,409 $11.5 Million
Q1 2021

May 13, 2021

SELL
$61.35 - $90.47 $354,234 - $522,373
-5,774 Reduced 3.31%
168,640 $11.2 Million
Q4 2020

Feb 12, 2021

SELL
$43.82 - $85.37 $199,775 - $389,201
-4,559 Reduced 2.55%
174,414 $13.4 Million
Q3 2020

Nov 13, 2020

BUY
$33.21 - $51.27 $1.68 Million - $2.59 Million
50,610 Added 39.43%
178,973 $7.71 Million
Q2 2020

Aug 06, 2020

SELL
$26.12 - $43.27 $413,975 - $685,786
-15,849 Reduced 10.99%
128,363 $5.54 Million
Q1 2020

May 11, 2020

BUY
$20.56 - $63.12 $36,391 - $111,722
1,770 Added 1.24%
144,212 $4.15 Million
Q4 2019

Feb 11, 2020

BUY
$28.14 - $73.01 $3.91 Million - $10.1 Million
138,919 Added 3943.2%
142,442 $9.04 Million
Q3 2019

Nov 14, 2019

BUY
$26.26 - $34.86 $2,888 - $3,834
110 Added 3.22%
3,523 $99,000
Q2 2019

Aug 12, 2019

BUY
$17.43 - $28.82 $59,488 - $98,362
3,413 New
3,413 $90,000

Others Institutions Holding ARWR

About ARROWHEAD PHARMACEUTICALS, INC.


  • Ticker ARWR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,849,000
  • Market Cap $2.29B
  • Description
  • Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...
More about ARWR
Track This Portfolio

Track Mutual Of America Capital Management LLC Portfolio

Follow Mutual Of America Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mutual Of America Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mutual Of America Capital Management LLC with notifications on news.